Search Results - pradip+bajgain

1 Results

Sort By:

Fully Human Chimeric Antigen Receptors Against CD276 for the Treatment of Solid Tumors

Summary The National Cancer Institute (NCI) seeks research co-development partners and licensees for a panel of five fully human antibodies against CD276 for the treatment of solid tumors. The collection also includes human CARs incorporating the antibodies for immunotherapeutic use. Description of Technology Chimeric antigen receptor (CAR)-T cell...

Published: 6/9/2025 | Inventor(s): Brad St. Croix, Pradip Bajgain, Yang Feng

Keywords(s):

Category(s): Application > Therapeutics, Collaboration Sought > Collaboration, TherapeuticArea > Oncology, TherapeuticArea > Immunology, Collaboration Sought > Licensing